{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T23:23:02Z","timestamp":1749424982965},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Growing evidence suggests that mutations in the connection domain of the HIV-1 reverse transcriptase (RT) can contribute to viral resistance to RT inhibitors. This work was designed to determine the effects of a novel mutation, D404N, in the connection subdomain of RT of HIV-1 CRF08_BC subtype on drug resistance, viral replication capacity (RC) and RT activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Mutation D404N, alone or together with the other reported mutations, was introduced into an HIV-1 CRF08_BC subtype infectious clone by site-directed mutagenesis. Viral susceptibility to nine RT inhibitors, viral RC and the DNA polymerase activity of viral RT of the constructed virus mutants were investigated. A modelling study using the server SWISS-MODEL was conducted to explore the possible structure-related drug resistance mechanism of the mutation D404N.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Single mutations D404N and H221Y conferred low-level resistance to nevirapine, efavirenz, rilpivirine and zidovudine. Double mutations Y181C\/D404N and Y181C\/H221Y significantly reduced susceptibility to NNRTIs. The most pronounced resistance to NNRTIs was observed with the triple mutation Y181C\/D404N\/H221Y. Virus containing D404N as the only mutation displayed \u223c50% RC compared with the WT virus. The modelling study suggested that the D404N mutation might abolish the hydrogen bonds between residues 404 and K30 in p51 or K431 in p66, leading to impaired RT subunit structure and enhanced drug resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results indicate that D404N is a novel NNRTI-associated mutation in the HIV-1 subtype CRF08_BC and provides information valuable for the monitoring of clinical RTI resistance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dku565","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T05:56:16Z","timestamp":1422683776000},"page":"1381-1390","source":"Crossref","is-referenced-by-count":5,"title":["A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs"],"prefix":"10.1093","volume":"70","author":[{"given":"Xiao-Min","family":"Zhang","sequence":"first","affiliation":[{"name":"1 \u00a0Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"2 \u00a0Biosafety Level-3 Laboratory, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence Chi-Kong","family":"Lau","sequence":"additional","affiliation":[{"name":"3 \u00a0Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hin","family":"Chu","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yan","family":"Jin","sequence":"additional","affiliation":[{"name":"4 \u00a0Department of Biochemistry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Jian","family":"Zheng","sequence":"additional","affiliation":[{"name":"1 \u00a0Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"2022020121021463500_DKU565C1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/cid\/cis501","article-title":"Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors","volume":"55","author":"Brehm","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2022020121021463500_DKU565C2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virusres.2007.12.015","article-title":"Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase","volume":"134","author":"Menendez-Arias","year":"2008","journal-title":"Virus Res"},{"key":"2022020121021463500_DKU565C3","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1021\/jm901167t","article-title":"Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase","volume":"52","author":"Cullen","year":"2009","journal-title":"J Med Chem"},{"key":"2022020121021463500_DKU565C4","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/v2071476","article-title":"The \u201cconnection\u201d between HIV drug resistance and RNase H","volume":"2","author":"Delviks-Frankenberry","year":"2010","journal-title":"Viruses"},{"key":"2022020121021463500_DKU565C5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 antiretroviral resistance: scientific principles and clinical applications","volume":"72","author":"Tang","year":"2012","journal-title":"Drugs"},{"key":"2022020121021463500_DKU565C6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2011.08.020","article-title":"HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors","volume":"92","author":"Menendez-Arias","year":"2011","journal-title":"Antiviral Res"},{"key":"2022020121021463500_DKU565C7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.0609642104","article-title":"Mutations in the connection domain of HIV-1 reverse transcriptase increase 3\u2032-azido-3\u2032-deoxythymidine resistance","volume":"104","author":"Nikolenko","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020121021463500_DKU565C8","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1128\/AAC.00870-09","article-title":"Combinations of mutations in the connection domain of human immunodeficiency virus type 1 reverse transcriptase: assessing the impact on nucleoside and nonnucleoside reverse transcriptase inhibitor resistance","volume":"54","author":"Gupta","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021463500_DKU565C9","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/JVI.01154-07","article-title":"Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors","volume":"82","author":"Hachiya","year":"2008","journal-title":"J Virol"},{"key":"2022020121021463500_DKU565C10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1570162043351093","article-title":"Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding","volume":"2","author":"Sluis-Cremer","year":"2004","journal-title":"Curr HIV Res"},{"key":"2022020121021463500_DKU565C11","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1073\/pnas.0804660105","article-title":"HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision","volume":"105","author":"Delviks-Frankenberry","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020121021463500_DKU565C12","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1073\/pnas.0409823102","article-title":"Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision","volume":"102","author":"Nikolenko","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"2022020121021463500_DKU565C13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/QAI.0b013e3181c7d363","article-title":"The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China","volume":"53","author":"Liao","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022020121021463500_DKU565C14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/455609a","article-title":"The changing face of HIV in China","volume":"455","author":"Lu","year":"2008","journal-title":"Nature"},{"key":"2022020121021463500_DKU565C15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/157016212799937236","article-title":"HIV-1 CRF_BC recombinants infection in China: molecular epidemic and characterizations","volume":"10","author":"Ouyang","year":"2012","journal-title":"Curr HIV Res"},{"key":"2022020121021463500_DKU565C16","doi-asserted-by":"crossref","first-page":"e91803","DOI":"10.1371\/journal.pone.0091803","article-title":"Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study","volume":"9","author":"Sui","year":"2014","journal-title":"PLoS One"},{"key":"2022020121021463500_DKU565C17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/1471-2334-12-382","article-title":"Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Infect Dis"},{"key":"2022020121021463500_DKU565C18","doi-asserted-by":"crossref","first-page":"e72630","DOI":"10.1371\/journal.pone.0072630","article-title":"Prevalence and mutation patterns of HIV drug resistance from 2010 to 2011 among ART-failure individuals in the Yunnan Province, China","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"2022020121021463500_DKU565C19","article-title":"In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors","author":"Wu","year":"2014","journal-title":"AIDS Res Hum Retro"},{"key":"2022020121021463500_DKU565C20","doi-asserted-by":"crossref","first-page":"e31233","DOI":"10.1371\/journal.pone.0031233","article-title":"Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"2022020121021463500_DKU565C21","doi-asserted-by":"crossref","first-page":"e6108","DOI":"10.1371\/journal.pone.0006108","article-title":"The Y271 and I274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"2022020121021463500_DKU565C22","doi-asserted-by":"crossref","first-page":"e44333","DOI":"10.1371\/journal.pone.0044333","article-title":"Identification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitro","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"2022020121021463500_DKU565C23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/QAD.0b013e32835d9f6d","article-title":"Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline","volume":"27","author":"Asahchop","year":"2013","journal-title":"AIDS"},{"key":"2022020121021463500_DKU565C24","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/AAC.01795-09","article-title":"The M230L nonnucleoside reverse transcriptase inhibitor resistance mutation in HIV-1 reverse transcriptase impairs enzymatic function and viral replicative capacity","volume":"54","author":"Xu","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021463500_DKU565C25","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1093\/nar\/gku487","article-title":"Structures of HIV-1 RT-RNA\/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA\/DNA: insights into requirements for RNase H cleavage","volume":"42","author":"Das","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2022020121021463500_DKU565C26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"2022020121021463500_DKU565C27","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"Johnson","year":"2013","journal-title":"Top Antivir Med"},{"key":"2022020121021463500_DKU565C28","doi-asserted-by":"crossref","first-page":"e74078","DOI":"10.1371\/journal.pone.0074078","article-title":"A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"2022020121021463500_DKU565C29","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1371\/journal.pmed.0040335","article-title":"N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance","volume":"4","author":"Yap","year":"2007","journal-title":"PLoS Med"},{"key":"2022020121021463500_DKU565C30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/AAC.00986-09","article-title":"TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1","volume":"54","author":"Azijn","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021463500_DKU565C31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/QAD.0b013e3283584500","article-title":"Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies","volume":"27","author":"Anta","year":"2013","journal-title":"AIDS"},{"key":"2022020121021463500_DKU565C32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jac\/dkq140","article-title":"Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations","volume":"65","author":"Reuman","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2022020121021463500_DKU565C33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/AAC.01192-10","article-title":"Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes","volume":"55","author":"Asahchop","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2022020121021463500_DKU565C34","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1128\/JVI.00303-07","article-title":"Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors","volume":"81","author":"Ceccherini-Silberstein","year":"2007","journal-title":"J Virol"},{"key":"2022020121021463500_DKU565C35","article-title":"The impact of resistance on viral fitness and its clinical implications","volume-title":"Antiretroviral Resistance in Clinical Practice","author":"De Luca","year":"2006"},{"key":"2022020121021463500_DKU565C36","doi-asserted-by":"crossref","first-page":"586401","DOI":"10.1155\/2012\/586401","article-title":"HIV-1 reverse transcriptase still remains a new drug target: structure, function, classical inhibitors, and new inhibitors with innovative mechanisms of actions","volume":"2012","author":"Esposito","year":"2012","journal-title":"Mol Biol Int"},{"key":"2022020121021463500_DKU565C37","first-page":"S79","article-title":"Reverse transcriptase mutations that confer non-nucleoside reverse transcriptase inhibitor resistance may also impair replication capacity","volume":"7","author":"Huang","year":"2002","journal-title":"Antivir Ther"},{"key":"2022020121021463500_DKU565C38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","article-title":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo","volume":"134","author":"Martinez-Picado","year":"2008","journal-title":"Virus Res"},{"key":"2022020121021463500_DKU565C39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989\u20132009)","volume":"85","author":"de Bethune","year":"2010","journal-title":"Antiviral Res"},{"key":"2022020121021463500_DKU565C40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JVI.78.2.603-611.2004","article-title":"Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants","volume":"78","author":"Collins","year":"2004","journal-title":"J Virol"},{"key":"2022020121021463500_DKU565C41","first-page":"423","article-title":"Impact of HIV-1 reverse transcriptase H221Y mutation on replication capacity of Y181C mutant viral strain","volume":"33","author":"Yin","year":"2013","journal-title":"Chin J Microb Immunol"},{"key":"2022020121021463500_DKU565C42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nsmb.2485","article-title":"Complexes of HIV-1 RT, NNRTI and RNA\/DNA hybrid reveal a structure compatible with RNA degradation","volume":"20","author":"Lapkouski","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"2022020121021463500_DKU565C43","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1128\/JVI.74.18.8390-8401.2000","article-title":"Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture","volume":"74","author":"Archer","year":"2000","journal-title":"J Virol"},{"key":"2022020121021463500_DKU565C44","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/protein\/10.12.1379","article-title":"Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase action","volume":"10","author":"Kroeger Smith","year":"1997","journal-title":"Protein Eng"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/5\/1381\/42355299\/jac_70_5_1381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/70\/5\/1381\/42355299\/jac_70_5_1381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T21:08:45Z","timestamp":1643749725000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/70\/5\/1381\/691143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,1,29]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku565","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,1,29]]}}}